| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/03/2011 | WO2011066436A2 Gluten quality wheat varieties and methods of use |
| 06/03/2011 | WO2011066423A2 Gluten quality wheat varieties and methods of use |
| 06/03/2011 | WO2011066403A1 Differentiation of human embryonic and induced pluripotents stem cells |
| 06/03/2011 | WO2011066382A1 Control of aad dicot volunteers in monocot crops |
| 06/03/2011 | WO2011066101A1 Multi-purpose substrates useful for cell culture and methods for making and using the same |
| 06/03/2011 | WO2011066048A1 Cell-based anti-cancer compositions and methods of making and using the same |
| 06/03/2011 | WO2011065715A2 Method of preparing cells susceptible to transmissible spongiform encephalopathy and the creation of tse persistently infected cells |
| 06/03/2011 | WO2011065672A2 Method for producing medical dressing using pig skin |
| 06/03/2011 | WO2011065661A2 Chondrogenesis of mesenchymal stem cells using dkk-1 or sfrp-1 |
| 06/03/2011 | WO2011065389A1 Method for screening of therapeutic agent for hyperlipemia |
| 06/03/2011 | WO2011065363A1 Atmosphere control composition |
| 06/03/2011 | WO2011064733A1 Methods of preparing mesenchymal stem cells, compositions and kit thereof |
| 06/03/2011 | WO2011064669A2 Adherent cells from placenta and use of same in disease treatment |
| 06/03/2011 | WO2011064549A2 Composition and method for differentiation of human embryonic stem cells |
| 06/03/2011 | WO2011064309A1 Method for hepatic differentiation of definitive endoderm cells |
| 06/03/2011 | WO2011063707A1 Dehydrin-like gene of cotton and uses thereof |
| 06/03/2011 | WO2011063706A1 Gene of cotton transcription factor nac and use thereof |
| 06/03/2011 | WO2011063462A1 A method of inducing cellular growth and materials for use therewith |
| 06/03/2011 | WO2011021194A3 Pericyte progenitor cells and methods of generating and using same |
| 06/03/2011 | WO2011019630A3 Treatment of brain metastases with inhibitors of endothelin receptors in combination with a cytotoxic chemotherapy agent |
| 06/03/2011 | WO2011017315A3 Methods and compositions for targeted gene modification |
| 06/03/2011 | WO2010129485A3 Compositions and methods for identifying enzyme and transport protein inhibitors |
| 06/03/2011 | CA2782176A1 Methods and apparatus for segregation of particles, including segregation and proliferation of fetal and stem cells |
| 06/03/2011 | CA2781649A1 Adherent cells from placenta and use of same in disease treatment |
| 06/03/2011 | CA2777232A1 Methods of preparing mesenchymal stem cells, compositions and kit thereof |
| 06/02/2011 | US20110131687 Polypeptides having arabinofuranosidase activity and polynucleotides encoding same |
| 06/02/2011 | US20110131686 Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
| 06/02/2011 | US20110131684 Plants Having Enhanced Yield-Related Traits and a Method for Making the Same |
| 06/02/2011 | US20110131682 Means and Methods for Controlling Flowering in Plants |
| 06/02/2011 | US20110131680 Method of enhancing gene expression in plants |
| 06/02/2011 | US20110131679 Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement |
| 06/02/2011 | US20110131678 Compositions and methods for differential regulation of fatty acid unsaturation in membrane lipids and seed oil |
| 06/02/2011 | US20110131672 Stress resistant plants |
| 06/02/2011 | US20110131670 Non-Aggregating Fluorescent Proteins and Methods for Using the Same |
| 06/02/2011 | US20110131668 Improved gene silencing methods |
| 06/02/2011 | US20110131667 Tumor Model System Useful to Study Multistage Cancer |
| 06/02/2011 | US20110130443 Compositions And Methods For Inhibiting Expression Of Factor V Leiden Mutant Gene |
| 06/02/2011 | US20110130442 Nucleic acid capable of controlling degranulation of mast cell |
| 06/02/2011 | US20110130441 Oligomeric compounds having at least one neutrally linked terminal bicyclic nucleosides |
| 06/02/2011 | US20110130440 Non-natural ribonucleotides, and methods of use thereof |
| 06/02/2011 | US20110130387 Sirtuin modulating compounds |
| 06/02/2011 | US20110130386 Dna-pk inhibitors |
| 06/02/2011 | US20110130347 Identification of new splice-variants of g-protein coupled receptor ep3 and uses thereof |
| 06/02/2011 | US20110130346 Peptide conjugates for delvery of biologically active compounds |
| 06/02/2011 | US20110130344 Tight junction protein modulators and uses thereof |
| 06/02/2011 | US20110130343 Immunity-inducing agent and method for detection of cancer |
| 06/02/2011 | US20110130329 Glp-1 Fusion Peptides, Their Production and Use |
| 06/02/2011 | US20110130327 Multi-Arm Amines and Uses Thereof |
| 06/02/2011 | US20110129928 Method of Manufacturing Induced Pluripotent Stem Cell Originated from Somatic Cell |
| 06/02/2011 | US20110129927 Chinese hamster apoptosis-related genes |
| 06/02/2011 | US20110129926 Dry powder cell culture products and methods of production thereof |
| 06/02/2011 | US20110129925 Zeolite and bone mimetic zeolite based coatings for bioimplants |
| 06/02/2011 | US20110129924 Porous Polymeric Articles |
| 06/02/2011 | US20110129923 Cell culture methods and devices utilizing gas permeable materials |
| 06/02/2011 | US20110129922 Method for inducing differentiation into cardiomyocytes using g-csf |
| 06/02/2011 | US20110129921 Targeted polymer bioconjugates |
| 06/02/2011 | US20110129920 Biomarkers for alzheimer's disease |
| 06/02/2011 | US20110129919 Microcarriers for Stem Cell Culture |
| 06/02/2011 | US20110129918 Method for expanding mesenchymal stem cells in low-density and hypoxic culture |
| 06/02/2011 | US20110129917 Cell isolation method |
| 06/02/2011 | US20110129916 Monoclonal antibodies with specificity for fetal erythroid cells |
| 06/02/2011 | US20110129915 Apparatus and method for incubating cell cultures |
| 06/02/2011 | US20110129898 Methods and compositions for increasing nuclease activity |
| 06/02/2011 | US20110129883 Inactivation of genes of the mep pathway |
| 06/02/2011 | US20110129875 Immunosupprressive polypeptides and nucleic acids |
| 06/02/2011 | US20110129868 Cell capable of replicating novel hcv replicon, cell capable of replicating full-length hcv rna, and use of those cells |
| 06/02/2011 | US20110129867 Compound Screening Using Chondrocytes |
| 06/02/2011 | US20110129855 Recombinant Anti-Epidermal Growth Factor Receptor Antibody Compositions |
| 06/02/2011 | US20110129852 Organic compounds |
| 06/02/2011 | US20110129586 White wheat varieties, and compositions and methods of using the same |
| 06/02/2011 | US20110129515 Devices and Methods for Nerve Regeneration |
| 06/02/2011 | US20110129503 Tumor vaccination in combination with hematopoietic cell transplantation for cancer therapy |
| 06/02/2011 | US20110129502 Immunogenic Constructs |
| 06/02/2011 | US20110129500 Lawsonia intracellularis bacterium of a novel serotype, vaccine based on that bacterium, antibodies suitable for diagnosing the novel lawsonia intracellularis serotype and hybridomas for producing the said antibodies |
| 06/02/2011 | US20110129493 Combined measles-human papilloma vacine |
| 06/02/2011 | US20110129490 Modulation of production of retroviruses by apobec4 |
| 06/02/2011 | US20110129483 Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy |
| 06/02/2011 | US20110129481 Antibody specifically binding to c-Met and methods of use |
| 06/02/2011 | US20110129480 Anti-ferroportin 1 monoclonal antibodies and uses thereof |
| 06/02/2011 | US20110129477 NOGO Receptor Homologs |
| 06/02/2011 | US20110129474 Methods And Systems For Multi-Antibody Therapies |
| 06/02/2011 | US20110129471 Chronic lymphocytic leukemia cell line |
| 06/02/2011 | US20110129470 Use of specifically engineered enzymes to enhance the efficacy of prodrugs |
| 06/02/2011 | US20110129466 Methods of treating cancer by administering antibodies to cd200 |
| 06/02/2011 | US20110129464 Humanized anti-erbb2 antibodies and treatment with anti-erbb2 antibodies |
| 06/02/2011 | US20110129461 Mat II Beta Subunit RNAi and Therapeutic Methods Using Same |
| 06/02/2011 | US20110129458 Binding molecules with multiple binding sites, compositions comprising the same and uses thereof |
| 06/02/2011 | US20110129457 Variant hhip1 protein and methods and uses thereof |
| 06/02/2011 | US20110129450 Method of promoting neurogenesis by modulating secretase activities |
| 06/02/2011 | US20110129449 Compensating for atrioventricular block using a nucleic acid encoding a sodium channel or gap junction protein |
| 06/02/2011 | US20110129447 Methods for Cell Expansion and Uses of Cells and Conditioned Media Produced Thereby for Therapy |
| 06/02/2011 | US20110129443 Macrocyclic serine protease inhibitors |
| 06/02/2011 | US20110129439 Conditioned medium of liver progenitor cells |
| 06/02/2011 | US20110129414 Single Chain Fragment of Monoclonal Antibody 9B9 and Uses Thereof |
| 06/02/2011 | US20110129412 Antibodies Directed to CD20 and Uses Thereof |
| 06/02/2011 | US20110126453 New method for the production of somatic embryos from euphorbia pulcherrima plant tissue |
| 06/01/2011 | EP2327985A2 T1R Hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 06/01/2011 | EP2327778A1 Nucleic acid occurring in blood from hepatitis patient, polypeptide encoded by the nucleic acid, and use of the same |
| 06/01/2011 | EP2327775A2 Therapy for alpha-galactosidase a deficiency |
| 06/01/2011 | EP2327768A2 Permuted and nonpermuted luciferase biosensors |